The effect of F11, SH3BGRL3, SPATA20 and SWAP70 on each subtype was mediated by Factor XI inhibitors, atrial fibrillation, type 2 diabetes and systolic blood pressure, respectively (P < 0.05). This evidence concerns the gene SH3BGRL3 and type 2 diabetes mellitus.